Wicharn Luesomboon

Cognitive Function and Neurodevelopmental Outcomes in HIV-infected Children Older Than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy

Thanyawee Puthanakit, Jintanat Ananworanich, Vonthanak Saphonn et al. · The Pediatric Infectious Disease Journal · 2012 · 148 citations

Public Health, Child Health, Pediatrics +16

Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV

Stephen J. Kerr, Thanyawee Puthanakit, Ung Vibol et al. · AIDS Care · 2014 · 93 citations

Public Health, Child Health, Pediatrics +17

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial

Thanyawee Puthanakit, Vonthanak Saphonn, Jintanat Ananworanich et al. · The Lancet Infectious Diseases · 2012 · 81 citations · Full text

Medicine, Child Health, Pediatrics +11

Nevirapine‐associated toxicity in HIV‐infected Thai men and women, including pregnant women

Nittaya Phanuphak, Tanakorn Apornpong, Somsong Teeratakulpisarn et al. · HIV Medicine · 2007 · 53 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial

Aditya H. Gaur, Hilda Kizito, Wasana Prasitsueubsai et al. · The Lancet HIV · 2016 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +17